TauRx at AAIC 2023
As sponsors of the Alzheimer’s Association International Conference® (AAIC®) in Amsterdam 16 – 20 July, together with joint venture company GT Diagnostics, we will be presenting our latest research in neurodegenerative conditions.
AAIC is the largest annual medical meeting dedicated to advancing dementia science, bringing together leaders in the space to share the latest research.
To learn more about neurofilaments and tau, please click on the links below:
- Tau And Tau Pathology In Neurodegenerative Disease
- Neurofilament Light Chain (NfL) in Neurodegenerative Diseases
Follow along on LinkedIn and Twitter for more information from AAIC 2023.
Recent News
GT Diagnostics announces release of self-administered assessment tool aiding diagnosis of dementia, HiPAL Pro.
Sep 05, 2023
#AAIC23 may have come to a close, but we left Amsterdam with key insights that will drive our work this year.
Jul 21, 2023
TauRx’s hydromethylthionine mesylate (HMTM) demonstrates significant reduction in neurodegeneration in Alzheimer’s Disease (AD)
Jul 16, 2023
TauRx is a proud sponsor of AAIC 2023 where we can connect and collaborate with colleagues, share important clinical updates on the recently completed LUCIDITY Phase 3 trial, and support advances for people living with Alzheimer's.
Jun 22, 2023